Related Experiment Video
Updated: Jun 26, 2025

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
Published on: July 22, 2020
Cell type specific long non-coding RNA targets identified by integrative analysis of single-cell and bulk colorectal
Ante Mihaljevic1,2, Philip D Rubin1,2, Panagiotis Chouvardas3,4
1Department for BioMedical Research, University of Bern, 3008, Bern, Switzerland.
Abstract:
Long non-coding RNAs (lncRNAs) represent an emerging class of genes which play significant and diverse roles in human cancers. Nevertheless, the functional repertoires of lncRNAs in cancer cell subtypes remains unknown since most studies are focused on protein coding genes. Here, we explored the contribution of lncRNAs in Colorectal Cancer (CRC) heterogeneity. We analyzed 49'436 single-cells from 29 CRC patients and showed that lncRNAs are significantly more cell type specific compared to protein-coding genes. We identified 996 lncRNAs strongly enriched in epithelial cells. Among these, 98 were found to be differentially expressed in tumor samples compared to normal controls, when integrating 270 bulk CRC profiles. We validated the upregulation of two of them (CASC19 and LINC00460) in CRC cell lines and showed their involvement in CRC proliferation by CRISPR-Cas9 knock down experiments. This study highlights a list of novel RNA targets for potential CRC therapeutics, substantiated through experimental validation.
Insights
Long non-coding RNAs (lncRNAs) are highly cell-type specific in colorectal cancer (CRC). Researchers identified novel lncRNA targets, like CASC19 and LINC00460, for potential CRC therapeutics.
Area of Science:
- Genomics
- Cancer Biology
- Molecular Oncology
Background:
- Long non-coding RNAs (lncRNAs) are increasingly recognized for their roles in human cancers.
- Functional studies of lncRNAs in cancer cell subtypes are limited, with a focus on protein-coding genes.
- Understanding lncRNA contributions to Colorectal Cancer (CRC) heterogeneity is crucial.
Purpose of the Study:
- To explore the role and specificity of lncRNAs in Colorectal Cancer (CRC) heterogeneity.
- To identify novel lncRNAs enriched in CRC epithelial cells and differentially expressed in tumors.
- To experimentally validate the functional significance of specific lncRNAs in CRC proliferation.
Main Methods:
- Single-cell RNA sequencing of 49,436 cells from 29 CRC patients.
- Analysis of lncRNA cell-type specificity compared to protein-coding genes.
- Integration of bulk CRC expression data (270 profiles) to identify differentially expressed lncRNAs.
- Experimental validation of CASC19 and LINC00460 in CRC cell lines using CRISPR-Cas9 knockdown.
Main Results:
- lncRNAs demonstrated significantly higher cell-type specificity than protein-coding genes in CRC.
- 996 lncRNAs were identified as highly enriched in epithelial cells.
- 98 of these lncRNAs were differentially expressed in tumor versus normal CRC tissues.
- Upregulation of CASC19 and LINC00460 was confirmed, and their knockdown affected CRC proliferation.
Conclusions:
- lncRNAs play a significant role in CRC heterogeneity and exhibit distinct cell-type specific expression patterns.
- CASC19 and LINC00460 are identified as novel, upregulated lncRNAs implicated in CRC proliferation.
- These findings highlight potential new RNA-based therapeutic targets for Colorectal Cancer.
More Related Videos
07:23Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
Related Concept Videos
lncRNA - Long Non-coding RNAs
Non-LTR Retrotransposons